Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Glioma 11Glioblastoma 6Brain Neoplasms 4Neuroendocrine Tumors 3Hypoglycemia 3Congenital Hyperinsulinism 3Recurrence 2Parkinson Disease 2Oligodendroglioma 2Neuroblastoma 2Insulinoma 2Hyperinsulinism 2Gliosarcoma 2Ependymoma 2Astrocytoma 2Pheochromocytoma 1Parkinsonian Disorders 1Parathyroid Neoplasms 1Optic Nerve Glioma 1Neoplasms, Neuroepithelial 1Neoplasms 1Multiple Endocrine Neoplasia 1Lewy Body Disease 1Infant, Newborn, Diseases 1Hyperparathyroidism 1Hypercalcemia 1Glucose Metabolism Disorders 1Glioma, Subependymal 1Endocrine System Diseases 1Carcinoma, Medullary 1

Interventions

Valproic Acid 2Temozolomide 2Oncolytic Virotherapy 2Magnetic Resonance Spectroscopy 22-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2trametinib 1sonidegib 1ribociclib 1pembrolizumab 1palbociclib 1mirdametinib 1interferon gamma-1b 1imetelstat 1gallium Ga 68 dotatate 1fluorodopa F 18 1fludarabine phosphate 1fludarabine 1Verteporfin 1Thiotepa 1Tacrolimus 1Radiotherapy 1ONC206 1Mycophenolic Acid 1Melphalan 1Interleukin-12 1Interferon-gamma 1Immunotherapy 1Immunologic Techniques 1Granulocyte Colony-Stimulating Factor 1Gemcitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Neoplasms, Neuroepithelial × fluorodopa F 18 × Clear all
NCT02175745 2017-03-20

18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas

Stanford University

Phase NA Terminated
2 enrolled 7 charts
CNSSarcoma

Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Oligodendroglioma, Neoplasms, Neuroepithelial, Gliosarcoma, Optic Nerve Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡